HomeInsightsStock Comparison

Parnax Lab Ltd vs Supriya Lifescience Ltd Stock Comparison

Parnax Lab Ltd vs Supriya Lifescience Ltd Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

  • The Latest Trading Price of Parnax Lab Ltd is ₹ 162.35 as of 11 May 15:30 . The P/E Ratio of Parnax Lab Ltd changed from 15.7 on March 2022 to 10.7 on March 2025 . This represents a CAGR of -9.14% over 4 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Parnax Lab Ltd changed from ₹ 16.58 crore on March 2021 to ₹ 122.9 crore on March 2025 . This represents a CAGR of 49.28% over 5 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Parnax Lab Ltd for the Dec '25 is ₹ 63.91 crore as compare to the Sep '25 revenue of ₹ 63.23 crore. This represent the growth of 1.08% The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Parnax Lab Ltd for the Dec '25 is ₹ 6.68 crore as compare to the Sep '25 ebitda of ₹ 8.71 crore. This represent the decline of -23.31% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Parnax Lab Ltd changed from ₹ 3.99 crore to ₹ 2.72 crore over 7 quarters. This represents a CAGR of -19.66% The net profit of Supriya Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Parnax Lab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About Parnax Lab Ltd

  • Parnax Lab Limited, formerly Known as Krishna Deep Trade & Investment Limited was incorporated in August, 1982.
  • The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited with effect from July 19, 2012.
  • The Company engages in the business activities of manufacturing and export of Pharmaceutical Formulations.
  • Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company.
  • With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products.

About Supriya Lifescience Ltd

  • Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
  • The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
  • Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
  • It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
  • The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of Parnax Lab Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Parnax Lab Ltd or Supriya Lifescience Ltd?

Market cap of Parnax Lab Ltd is 186 Cr while Market cap of Supriya Lifescience Ltd is 5,775 Cr

What are the key factors driving the stock performance of Parnax Lab Ltd and Supriya Lifescience Ltd?

The stock performance of Parnax Lab Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parnax Lab Ltd and Supriya Lifescience Ltd?

As of May 12, 2026, the Parnax Lab Ltd stock price is INR ₹162.35. On the other hand, Supriya Lifescience Ltd stock price is INR ₹717.55.

How do dividend payouts of Parnax Lab Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Parnax Lab Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions